Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma

被引:0
|
作者
Tao, Haisu [1 ,2 ]
Zhang, Yuxin [1 ,2 ]
Yuan, Tong [1 ,2 ]
Li, Jiang [1 ,2 ]
Liu, Junjie [1 ,2 ]
Xiong, Yixiao [1 ,2 ]
Zhu, Jinghan [1 ,2 ]
Huang, Zhiyong [1 ,2 ]
Wang, Ping [3 ]
Liang, Huifang [1 ,2 ]
Zhang, Erlei [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Peoples R China
[2] Hubei Key Lab Hepatopancreato Biliary Dis, Wuhan, Peoples R China
[3] Guangzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou, Peoples R China
来源
AGING-US | 2022年 / 14卷 / 03期
基金
中国国家自然科学基金;
关键词
HCC; EMT; prognostic signature; LINC01116; immune; MESENCHYMAL TRANSITION; METASTASIS; EZH2;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Epithelial-mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established a novel EMT-related lncRNA signature in HCC and identified hub lncRNAs that can serve as potential therapeutic targets. Differentially expressed lncRNAs were identified by screening HCC patient data from The Cancer Genome Atlas, and a correlation analysis was performed to identify those associated with EMT. The EMT-related lncRNA signature was established by univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses. After verifying the prognostic accuracy of the signature, its relationships to immune cell infiltration and immune checkpoint targets were explored. LINC01116 was identified as a hub lncRNA and its role in HCC was investigated in vitro and in vivo. YResults: A 5-lncRNA signature was developed for HCC and its prognostic accuracy was assessed by survival, time-dependent receiver operating characteristic curve, clinical correlation, and Cox regression analyses. The correlation analysis showed that the lncRNA signature was closely related to immune cell infiltration and 10 immune checkpoint targets and also predicted the prognosis of HCC patients with high accuracy. In vitro and in vivo experiments revealed that LINC01116 stimulated cell proliferation, cell cycle progression, and tumor metastasis. We also found that LINC01116 was closely related to immune regulation. Conclusions: These results demonstrate that LINC01116 is an immune-related oncogene that is associated with both EMT and immune regulation in HCC. Moreover, the EMT-related lncRNA signature that includes LINC01116 can guide risk stratification and clinical decision-making in HCC management.
引用
收藏
页码:1473 / 1491
页数:19
相关论文
共 50 条
  • [21] Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
    Yu, Wanli
    Ma, Yanan
    Hou, Wenbin
    Wang, Fang
    Cheng, Wan
    Qiu, Feng
    Wu, Pengfei
    Zhang, Guohua
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [22] Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
    Hua, Shan
    Xie, Zhiwen
    Wang, Wenhao
    Wan, Zhong
    Chen, Min
    Zhao, Sheng
    Jiang, Juntao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Identification and validation of immune-related lncRNA prognostic signature for breast cancer
    Shen, Yong
    Peng, Xiaowei
    Shen, Chuanlu
    GENOMICS, 2020, 112 (03) : 2640 - 2646
  • [24] Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
    Zhao, Kai
    Zhang, Qijie
    Zeng, Tengyue
    Zhang, Jiayi
    Song, Ninghong
    Wang, Zengjun
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (03) : 1229 - +
  • [25] Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma
    Wu, Lei
    Quan, Wen
    Luo, Qiong
    Pan, Ying
    Peng, Dongxu
    Zhang, Guihai
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [26] Identification and Construction of a Predictive Immune-Related lncRNA Signature Model for Melanoma
    Li, Fang-Wei
    Luo, Sheng-Kang
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 9227 - 9235
  • [27] Identification and analysis of immune-related subtypes of hepatocellular carcinoma
    Wang, Qimeng
    Huang, Jin
    Zhang, Huihua
    Liu, Huan
    Yu, Min
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (06) : 667 - 677
  • [28] Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular Carcinoma
    Li, Ling
    Zhao, Huijia
    Chen, Binyao
    Huang, Kang
    Hao, Zhuowen
    Fan, Zhipeng
    Sun, Gongpeng
    Wu, Jianguo
    Li, Ning
    Ye, Qifa
    Yue, Jiang
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [29] EMT-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Hepatocellular Carcinoma
    Cao, Dan
    Liu, Huan
    Bai, Lang
    Tang, Hong
    DIGESTIVE DISEASES, 2023, 41 (02) : 282 - 295
  • [30] Construction and validation of an immune-related LncRNA prognostic model for hepatocellular carcinoma
    Xin, Chang
    Huang, Bin
    Chen, Mingliang
    Yan, Huanjun
    Zhu, Kelei
    Chen, Lei
    Jiang, Cunbing
    Zhang, Jianlei
    Wu, Yifeng
    CYTOKINE, 2022, 156